VIMOVO

Land: Israël

Taal: Engels

Bron: Ministry of Health

Werkstoffen:

ESOMEPRAZOLE AS MAGNESIUM TRIHYDRATE 20 MG; NAPROXEN 500 MG

Beschikbaar vanaf:

ASTRA ZENECA ISRAEL LTD

ATC-code:

G02CC02

farmaceutische vorm:

TABLETS MODIFIED RELEASE

Toedieningsweg:

PER OS

Geproduceerd door:

ASTRA ZENECA AB., SWEDEN

Therapeutische categorie:

NAPROXEN

therapeutische indicaties:

Vimovo is a combination product that contains naproxen and esomeprazole. It is indicated for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis and to decrease the risk of developing gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers.Vimovo is not recommended for initial treatment of acute pain because the absorption of naproxen is delayed compared to absorption from other naproxen-containing products.

Autorisatie datum:

2011-12-01